Julia reported on the 10 patients and 10 controls in her presentation at the end of last year I seem to recall: http://forums.phoenixrising.me/inde...ion-transcript-and-video-november-2012.21357/ Still it is refreshing to see it picked up in the media and receive such apparent acclaim at this conference. I dare say they will be calling for more work to be completed - but this sounds like the 'cells-in-the-gym' experiment that she commented on.
See also local Newcastle coverage:
Newcastle University scientists showcase work to tackle ME
Also from the Newcastle facebook page comes news of the Rituximab and PBC trial:
"We thought details of another study that is currently going on in our group might be of interest to some people too. This is the first trial of rituximab with fatigue as the primary endpoint in patients with the fatigue associated disease PBC. We really believe that important things will be learnt from this study that might be important for people with CFS and ME."
You might recall from the presentation that PBC was often used as a comparison when looking at 'CFS/ME' on several of Julia's slides.
http://www.controlled-trials.com/ISRCTN03978701/?forumid=331851
See also local Newcastle coverage:
Newcastle University scientists showcase work to tackle ME
n.b. This use of up to '600,000' prevalence is getting on my nerves... grumble... mumble...
Also from the Newcastle facebook page comes news of the Rituximab and PBC trial:
"We thought details of another study that is currently going on in our group might be of interest to some people too. This is the first trial of rituximab with fatigue as the primary endpoint in patients with the fatigue associated disease PBC. We really believe that important things will be learnt from this study that might be important for people with CFS and ME."
You might recall from the presentation that PBC was often used as a comparison when looking at 'CFS/ME' on several of Julia's slides.
http://www.controlled-trials.com/ISRCTN03978701/?forumid=331851